anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

01 Logic Chain

Loop collection for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Matching slides 9,549
Current window 6,571-6,600
Pages 319
Rows per page 30
Loop: 01 Logic Chainclear collectionreset all
18 30 60

Loop

6,571-6,600 of 9,549

filter-aware
05
The chart uses a stacked area visualization to show cumulative growth across different industry verticals.D-Wave | Investor Presentation Deck | 28 slides · D-Wave
Pitch deck Investor relations Beat · InterestLoop · Logic Chain1 hit
06
The slide uses a circular grid layout to present six distinct value propositions.D-Wave | Investor Presentation Deck | 28 slides · D-Wave
Pitch deck Investor relations Beat · InterestLoop · Logic Chain1 hit
07
The slide uses a hub-and-spoke style diagram to categorize mathematical problem types into three buckets, then maps them to quantum computing modalities.D-Wave | Investor Presentation Deck | 28 slides · D-Wave
Pitch deck Investor relations Beat · InterestLoop · Logic Chain1 hit
08
The slide uses a dual-track timeline to contrast D-Wave's specific product history with the general industry's gate-model development.D-Wave | Investor Presentation Deck | 28 slides · D-Wave
Pitch deck Investor relations Beat · InterestLoop · Logic Chain1 hit
09
The slide uses a mix of bulleted statistics and circular callouts for key metrics.D-Wave | Investor Presentation Deck | 28 slides · D-Wave
Pitch deck Investor relations Beat · InterestLoop · Logic Chain1 hit
05
TPD stands for Targeted Protein Degradation. The slide uses a three-column framework to explain their competitive advantage.Kymera | Investor Presentation Deck | 46 slides · Kymera Therapeutics
Pitch deck Investor relations Beat · InterestLoop · Logic Chain1 hit
06
The slide uses a standard pharmaceutical pipeline table format.Kymera | Investor Presentation Deck | 46 slides · Kymera Therapeutics
Pitch deck Investor relations Beat · InterestLoop · Logic Chain1 hit
07
This is a stylistic section divider slide with an abstract background.Kymera | Investor Presentation Deck | 46 slides · Kymera Therapeutics
Pitch deck Investor relations Beat · DesireLoop · Logic Chain1 hit
08
The slide uses a biological pathway diagram to illustrate the mechanism of action for a drug candidate.Kymera | Investor Presentation Deck | 46 slides · Kymera Therapeutics
Pitch deck Investor relations Beat · DesireLoop · Logic Chain1 hit
09
Includes a mechanism of action diagram, a market data table, and a callout box on competitive limitations.Kymera | Investor Presentation Deck | 46 slides · Kymera Therapeutics
Pitch deck Investor relations Beat · DesireLoop · Logic Chain1 hit
10
Comparison of two distinct cohorts: Healthy Volunteers (SAD/MAD) vs. HS/AD Patient Cohort.Kymera | Investor Presentation Deck | 46 slides · Kymera Therapeutics
Pitch deck Investor relations Beat · DesireLoop · Logic Chain1 hit
11
Includes both a longitudinal line chart for IRAK4 degradation and a grouped bar chart with a supporting data table for cytokine inhibition.Kymera | Investor Presentation Deck | 46 slides · Kymera Therapeutics
Pitch deck Investor relations Beat · DesireLoop · Logic Chain1 hit
12
Includes PK/PD correlation, blood IRAK4 levels, skin exposure, and skin lesion IRAK4 reduction data.Kymera | Investor Presentation Deck | 46 slides · Kymera Therapeutics
Pitch deck Investor relations Beat · DesireLoop · Logic Chain1 hit
13
The charts show log2(fold change) for individual patients. The footnote defines the log2(fold change) values in terms of percentage decrease.Kymera | Investor Presentation Deck | 46 slides · Kymera Therapeutics
Pitch deck Investor relations Beat · DesireLoop · Logic Chain1 hit
14
Data compares 'All HS Patients' vs 'Moderate to Severe' subgroups across four metrics over 42 days.Kymera | Investor Presentation Deck | 46 slides · Kymera Therapeutics
Pitch deck Investor relations Beat · DesireLoop · Logic Chain1 hit
15
The slide includes a disclaimer that the comparison is not head-to-head and uses historical benchmarks.Kymera | Investor Presentation Deck | 46 slides · Kymera Therapeutics
Pitch deck Investor relations Beat · DesireLoop · Logic Chain1 hit
16
Data presented as mean +/- S.E. of mean; N=7 patients.Kymera | Investor Presentation Deck | 46 slides · Kymera Therapeutics
Pitch deck Investor relations Beat · DesireLoop · Logic Chain1 hit
17
The slide includes a disclaimer regarding the non-head-to-head nature of the comparison.Kymera | Investor Presentation Deck | 46 slides · Kymera Therapeutics
Pitch deck Investor relations Beat · DesireLoop · Logic Chain1 hit
18
The slide provides clinical safety data for the KT-474 drug candidate.Kymera | Investor Presentation Deck | 46 slides · Kymera Therapeutics
Pitch deck Investor relations Beat · DesireLoop · Logic Chain1 hit
15
The slide uses a before-after comparison format to highlight financial indicator shifts.SoftBank | Results Presentation Deck | 72 slides · SoftBank
Conference presentation Investor relations Beat · SatisfactionLoop · Logic Chain1 hit
16
The chart illustrates a bridge from 15.5T to 16.4T, resulting in a net increase of 0.9T.SoftBank | Results Presentation Deck | 72 slides · SoftBank
Conference presentation Investor relations Beat · SatisfactionLoop · Logic Chain1 hit
17
The chart shows a significant discount of share price relative to NAV per share, with percentage gaps labeled.SoftBank | Results Presentation Deck | 72 slides · SoftBank
Conference presentation Investor relations Beat · SatisfactionLoop · Logic Chain1 hit
18
The chart shows a recovery in equity value in Q2 FY2023, with Arm being a significant component.SoftBank | Results Presentation Deck | 72 slides · SoftBank
Conference presentation Investor relations Beat · SatisfactionLoop · Logic Chain1 hit
19
The chart tracks the percentage contribution of various assets (Alibaba, SoftBank Corp, SVF1, SVF2, LatAm Funds, T-Mobile/DT, Arm, Others) over four years.SoftBank | Results Presentation Deck | 72 slides · SoftBank
Conference presentation Investor relations Beat · SatisfactionLoop · Logic Chain1 hit
20
The chart displays quarterly data points over a 25-year period.SoftBank | Results Presentation Deck | 72 slides · SoftBank
Conference presentation Investor relations Beat · SatisfactionLoop · Logic Chain1 hit
03
Includes footnotes regarding revenue composition, session definitions, and non-GAAP reconciliation.Talkspace | Results Presentation Deck | 11 slides · Talkspace
Conference presentation Investor relations Beat · AttentionLoop · Logic Chain1 hit
04
Talkspace | Results Presentation Deck | 11 slidesTalkspace | Results Presentation Deck | 11 slides · Talkspace
Conference presentation Investor relations Beat · NeedLoop · Logic Chain1 hit
05
Talkspace | Results Presentation Deck | 11 slidesTalkspace | Results Presentation Deck | 11 slides · Talkspace
Conference presentation Investor relations Beat · NeedLoop · Logic Chain1 hit
06
The slide shows a downward trend in both operating expenses and adjusted EBITDA losses.Talkspace | Results Presentation Deck | 11 slides · Talkspace
Conference presentation Investor relations Beat · SatisfactionLoop · Logic Chain1 hit
07
The slide uses a comparison table to highlight changes in financial projections.Talkspace | Results Presentation Deck | 11 slides · Talkspace
Conference presentation Investor relations Beat · SatisfactionLoop · Logic Chain1 hit